MeiraGTx

MGTXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.210 B

$13.07 +2.19%

Close of 7 Aug 2026

Revenue

$81.4M

#2589 by revenue

Earnings

—

Not reported

Shares outstanding

81,446,126

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#45ImmaticsIMTX$1.29B
#46Vor BiopharmaVOR$1.28B
#47MeiraGTxMGTX$1.21B
#48AlvotechALVO$1.19B
#49Cullinan TherapeuticsCGEM$1.09B

Where these numbers come from

Share counts and financials for MeiraGTx are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.